Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Katherine Anne Janeway, M.D.

Concepts (401)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Osteosarcoma3920248967.300 Why?
Bone Neoplasms48202425275.470 Why?
Gastrointestinal Stromal Tumors1620216162.720 Why?
Neuroectodermal Tumors, Primitive, Peripheral42023432.020 Why?
Gastrointestinal Neoplasms820219531.230 Why?
Neoplasms302024221581.230 Why?
High-Throughput Nucleotide Sequencing9202436381.130 Why?
Succinate Dehydrogenase620161451.120 Why?
Child1032024801560.980 Why?
Sarcoma10202417930.950 Why?
Neoplasm Recurrence, Local21202392750.910 Why?
Protein-Tyrosine Kinases4202224230.900 Why?
Molecular Targeted Therapy13202428110.900 Why?
Clinical Trials, Phase II as Topic320166280.890 Why?
Receptor, Platelet-Derived Growth Factor alpha620193670.850 Why?
Fibromatosis, Aggressive320201260.830 Why?
Oncogene Proteins, Fusion8202316050.760 Why?
Neoplasms, Muscle Tissue12021670.750 Why?
Medical Oncology9202323210.720 Why?
Proto-Oncogene Proteins c-kit720197280.710 Why?
Ketones220181830.700 Why?
Furans220182000.690 Why?
Antineoplastic Agents122020136350.690 Why?
Antineoplastic Combined Chemotherapy Protocols192024117350.670 Why?
Paraganglioma520221420.650 Why?
Adolescent692024883050.650 Why?
Receptor, IGF Type 1420193780.610 Why?
Piperazines5202425190.580 Why?
Clinical Trials as Topic10202479990.580 Why?
Central Nervous System Neoplasms220239160.580 Why?
Genomics16202458170.570 Why?
Doxorubicin7202322150.530 Why?
Information Dissemination1202411270.520 Why?
Proto-Oncogene Proteins4202245090.510 Why?
Soft Tissue Neoplasms5202311560.510 Why?
Child, Preschool412024422510.500 Why?
Germ-Line Mutation10202418580.480 Why?
Pediatrics5202035940.470 Why?
Mutation222024300440.460 Why?
Gene Fusion320223560.450 Why?
Marketing of Health Services120151500.450 Why?
Adrenal Gland Neoplasms420227320.450 Why?
Protein Kinase Inhibitors10202356650.430 Why?
Cyclin-Dependent Kinase 4420245590.430 Why?
Humans13920247613260.420 Why?
Antibiotics, Antineoplastic120166780.420 Why?
TOR Serine-Threonine Kinases3202420600.400 Why?
Pheochromocytoma320223280.400 Why?
Sarcoma, Clear Cell22023720.390 Why?
Immunoconjugates120199540.390 Why?
Ambulatory Care Facilities120179340.360 Why?
Neoadjuvant Therapy3201928230.360 Why?
Cell Respiration120102020.350 Why?
Cyclin-Dependent Kinase 6320243470.350 Why?
Young Adult372024591960.350 Why?
Gene Amplification3202310860.340 Why?
Infant252024362020.340 Why?
Vincristine5202410360.340 Why?
DNA Mutational Analysis3201641080.340 Why?
Pyrimidines3202430250.330 Why?
Lung Neoplasms42023133330.320 Why?
Prognosis192023295880.300 Why?
Tissue Banks320201840.290 Why?
Feasibility Studies2202152470.280 Why?
Amyloid Precursor Protein Secretases220226180.280 Why?
Fibrosarcoma220203080.280 Why?
Phosphatidylinositol 3-Kinases2202428590.280 Why?
Patient Selection2201742440.280 Why?
Female6220243924850.270 Why?
Proteins1202160340.270 Why?
Electron Transport Complex II32019530.270 Why?
National Cancer Institute (U.S.)620242970.270 Why?
Ovarian Neoplasms1202348770.270 Why?
Male5820243606210.260 Why?
Genetic Predisposition to Disease72022178720.250 Why?
Pyrroles2202411260.250 Why?
Antibodies, Monoclonal3202391800.240 Why?
Ifosfamide420242320.230 Why?
Disease-Free Survival5202368150.220 Why?
Genetic Testing3201735380.220 Why?
Rare Diseases220216210.220 Why?
Busulfan120242580.220 Why?
Adult4020242211220.220 Why?
Myofibromatosis12023270.210 Why?
Receptor, Platelet-Derived Growth Factor beta220231840.210 Why?
Melphalan120244200.210 Why?
Internet1201530940.210 Why?
Genome, Human2201744230.210 Why?
Hematologic Neoplasms1201418960.200 Why?
BRCA1 Protein3202411550.200 Why?
Plasma Cell Granuloma, Pulmonary12021120.200 Why?
Cyclophosphamide3202422180.200 Why?
Receptor Protein-Tyrosine Kinases4202216240.200 Why?
BRCA2 Protein220248040.200 Why?
Glomus Tumor12022620.200 Why?
Phthalazines120243820.190 Why?
Transplantation, Autologous2202421150.190 Why?
Rhabdoid Tumor120232100.190 Why?
Topotecan120211320.190 Why?
Granuloma, Plasma Cell12022800.190 Why?
Neoplasms, Neuroepithelial12021420.190 Why?
Indenes12021580.190 Why?
Loss of Heterozygosity120236620.190 Why?
Indoles1200918320.180 Why?
Etoposide420246340.180 Why?
Polycythemia120211250.180 Why?
Pelvic Neoplasms120222470.180 Why?
Tandem Repeat Sequences120211800.180 Why?
Tetrahydronaphthalenes12020860.170 Why?
Infant, Newborn92024262110.170 Why?
Brain Neoplasms4202390300.170 Why?
Biomedical Research3202134290.170 Why?
Sequence Analysis, RNA4202120190.170 Why?
Treatment Outcome132024646450.170 Why?
DEAD-box RNA Helicases220203830.170 Why?
Neoplasms, Unknown Primary120201010.170 Why?
Myofibroma12019450.170 Why?
Receptor, erbB-22202425560.160 Why?
Chromosomes, Human, Pair 14220172870.160 Why?
Nomograms120202280.160 Why?
Benzamides3202313700.160 Why?
Valine120204080.160 Why?
Carcinoma, Medullary120191150.160 Why?
Kidney Neoplasms3202142460.160 Why?
Gene Expression Regulation, Neoplastic6202085270.150 Why?
Proto-Oncogene Proteins c-ret120202250.150 Why?
Drug Resistance, Neoplasm4201952970.150 Why?
Dystrophin120192830.150 Why?
Ribonuclease III120202780.150 Why?
Nephroma, Mesoblastic12017240.150 Why?
Epigenomics320199410.150 Why?
Parotid Neoplasms120191570.150 Why?
Resource Allocation120203500.150 Why?
Neoplasm Metastasis6201949080.150 Why?
Legislation, Drug120202140.150 Why?
DNA Repair2202420440.150 Why?
Tumor Suppressor Protein p533201929110.150 Why?
Glioma2202234550.140 Why?
Retrospective Studies172024805750.140 Why?
Vascular Endothelial Growth Factor Receptor-2120195460.140 Why?
Microtubule-Associated Proteins2202210750.140 Why?
Benzimidazoles120228580.140 Why?
Informed Consent1202310080.130 Why?
Li-Fraumeni Syndrome120171170.130 Why?
von Hippel-Lindau Disease120171510.130 Why?
Proto-Oncogene Proteins B-raf2202420520.130 Why?
Karyopherins120161320.130 Why?
Carcinoma, Neuroendocrine120193390.130 Why?
Specimen Handling120207030.130 Why?
Basic Helix-Loop-Helix Transcription Factors1202111350.130 Why?
SEER Program1202014490.130 Why?
Survival Rate52019127100.130 Why?
Genomic Imprinting120173300.120 Why?
Pelvic Bones120172700.120 Why?
Disease Models, Animal22014182340.120 Why?
Histone-Lysine N-Methyltransferase120196820.120 Why?
United States Food and Drug Administration3202216650.120 Why?
Pyridines2202428700.120 Why?
RNA, Neoplasm120177490.120 Why?
Immunotherapy, Adoptive1202414690.120 Why?
Pyrazines1201912000.110 Why?
Hematopoietic Stem Cell Transplantation2202456700.110 Why?
Imidazoles1201911790.110 Why?
United States152024723170.110 Why?
Endpoint Determination120165900.110 Why?
Cell Line, Tumor72022169660.110 Why?
Databases, Factual3202379540.110 Why?
Follow-Up Studies82020391080.110 Why?
Repressor Proteins2202129850.100 Why?
Age Factors52024184010.100 Why?
Prospective Studies102024544050.100 Why?
Leukemia1202115230.100 Why?
Poverty1202426970.100 Why?
Cisplatin3201916470.100 Why?
Drug Evaluation, Preclinical2201613370.100 Why?
Proteasome Endopeptidase Complex1201913190.100 Why?
Age of Onset1201933030.100 Why?
Serine Endopeptidases1201710210.100 Why?
Patient Participation1202114430.100 Why?
DNA Copy Number Variations2201920200.100 Why?
Glucocorticoids1202121630.100 Why?
Methotrexate3201917200.100 Why?
Extremities120178670.100 Why?
Gastrectomy120166710.100 Why?
Receptors, Cytoplasmic and Nuclear120168560.100 Why?
Combined Modality Therapy4202285260.100 Why?
Cerebellar Neoplasms120165860.090 Why?
Genetic Heterogeneity120147320.090 Why?
Cell Survival1202157920.090 Why?
Gene Dosage2201712180.090 Why?
Medulloblastoma120166780.090 Why?
Polyethylene Glycols1201611880.090 Why?
Membrane Proteins3201778520.090 Why?
Syndrome2202132680.090 Why?
Cell Cycle Proteins2202234480.090 Why?
RNA Processing, Post-Transcriptional120134150.090 Why?
Antidotes120101370.080 Why?
In Situ Hybridization, Fluorescence3202125090.080 Why?
MicroRNAs2201737960.080 Why?
DNA Damage3202424420.080 Why?
Germ Cells220236340.080 Why?
Heart Neoplasms120123620.080 Why?
Nasopharyngeal Neoplasms120112900.080 Why?
Treatment Failure2201726420.080 Why?
Mitogen-Activated Protein Kinases2202412460.080 Why?
Mediastinal Neoplasms120114020.080 Why?
Ecosystem220234900.070 Why?
Polymorphism, Single Nucleotide42017158790.070 Why?
Protein Subunits120109420.070 Why?
Dose-Response Relationship, Drug12019107640.070 Why?
Disease Progression52021135000.070 Why?
Translocation, Genetic2202313930.070 Why?
Pedigree1201445890.070 Why?
Survivors2202323700.070 Why?
Diagnosis, Differential12021129720.070 Why?
Head and Neck Neoplasms1202028910.070 Why?
Oncogenes2202212230.070 Why?
Thyroid Neoplasms1201923320.070 Why?
Neurotoxicity Syndromes120103000.070 Why?
Mice, Nude3201936030.060 Why?
Immunohistochemistry32019110700.060 Why?
Cyclin D12024720.060 Why?
Immunotherapy2202146490.060 Why?
Melanoma1202357060.060 Why?
Risk Assessment32020239810.060 Why?
Neoplastic Cells, Circulating120119460.060 Why?
Forecasting1201329280.060 Why?
Pancreatic Neoplasms1202153630.060 Why?
Neoplasm Transplantation2201920140.060 Why?
Computer Simulation1201762360.060 Why?
Clinical Protocols2202214400.050 Why?
Gene Expression Profiling5201794140.050 Why?
Infertility120106540.050 Why?
Blotting, Western1201050340.050 Why?
Adenocarcinoma1202063320.050 Why?
Biopsy3202067680.050 Why?
Nuclear Proteins2202357940.050 Why?
Cyclic AMP Response Element Modulator12023880.050 Why?
Vidarabine120243360.050 Why?
Hearing Loss120107830.050 Why?
Attitude of Health Personnel1201638890.050 Why?
Normetanephrine12021250.050 Why?
Lymphocyte Depletion120246020.050 Why?
Neoplasms, Second Primary1201010510.050 Why?
Dogs2201938390.050 Why?
Inflammation12021107600.050 Why?
Enzyme Activation1200735920.050 Why?
3-Iodobenzylguanidine120221140.050 Why?
Middle Aged1420242207740.050 Why?
Research Design2201761780.050 Why?
Chromogranins120211610.050 Why?
Trismus12020330.050 Why?
Microphthalmia-Associated Transcription Factor120232590.050 Why?
DNA Methylation4201743830.050 Why?
Sacrum120222760.050 Why?
Survival Analysis32018100750.050 Why?
Desmoplastic Small Round Cell Tumor12020330.040 Why?
Signal Transduction52021234270.040 Why?
Oncogene Proteins220177180.040 Why?
Aminopyridines120245730.040 Why?
RNA-Binding Protein EWS120212100.040 Why?
Poly(ADP-ribose) Polymerases120224260.040 Why?
Oncogene Fusion12020810.040 Why?
Cell Differentiation22023115310.040 Why?
RNA2202227230.040 Why?
Polymerase Chain Reaction1200960860.040 Why?
Phosphorylation1201083120.040 Why?
Mice62022814740.040 Why?
Codon120216020.040 Why?
Cell Cycle2201929300.040 Why?
Receptor, Notch1120224960.040 Why?
Mitogen-Activated Protein Kinase Kinases120226410.040 Why?
Animals920221683880.040 Why?
Kidney Diseases1201020930.040 Why?
Adrenal Glands120215510.040 Why?
RNA Interference2201928320.040 Why?
Xenograft Model Antitumor Assays2201835900.040 Why?
Cell Proliferation12014104310.040 Why?
Granulocyte-Macrophage Colony-Stimulating Factor120228920.040 Why?
Pathology, Molecular120213280.040 Why?
Workers' Compensation119991500.040 Why?
Calcitonin120193290.040 Why?
DNA Helicases120238510.040 Why?
Carbazoles120192200.040 Why?
Radionuclide Imaging1202219750.040 Why?
Endothelial Cells1201135430.040 Why?
Stem Cells1201135210.040 Why?
Proportional Hazards Models32017124500.040 Why?
Cohort Studies52021414400.040 Why?
GTP-Binding Proteins120229500.040 Why?
Drug Labeling120202480.040 Why?
Insulin-Like Growth Factor Binding Protein 212017680.040 Why?
American Cancer Society12017690.040 Why?
Utah120171310.040 Why?
Breast Neoplasms22022210090.040 Why?
MAP Kinase Signaling System1202414860.040 Why?
Heart Diseases1201027850.030 Why?
Receptors, Platelet-Derived Growth Factor120171780.030 Why?
Sequence Analysis, DNA2201847400.030 Why?
Proto-Oncogene Proteins c-ets120173130.030 Why?
Receptors, Fibroblast Growth Factor120171910.030 Why?
Minor Histocompatibility Antigens120172930.030 Why?
Necrosis1202016050.030 Why?
Comparative Genomic Hybridization120174730.030 Why?
MAP Kinase Kinase Kinases120172550.030 Why?
Safety1202011500.030 Why?
Aged820241691790.030 Why?
Carpal Tunnel Syndrome119993030.030 Why?
Educational Status1202325200.030 Why?
Exons1202123920.030 Why?
T-Lymphocytes22024101910.030 Why?
Practice Guidelines as Topic1201273890.030 Why?
Molecular Diagnostic Techniques120196110.030 Why?
Hydrazines120162240.030 Why?
Drug Synergism1201817570.030 Why?
Microarray Analysis120177480.030 Why?
Ubiquitin Thiolesterase120174550.030 Why?
Radiotherapy, Adjuvant1201917840.030 Why?
Proto-Oncogene Proteins p21(ras)1202217420.030 Why?
Ubiquitin120198380.030 Why?
Cytoskeletal Proteins1201913420.030 Why?
Data Collection1202333240.030 Why?
Drug Screening Assays, Antitumor120167160.030 Why?
Fluorodeoxyglucose F181202220090.030 Why?
Computational Biology2201735120.030 Why?
Motivation1202320060.030 Why?
Small Molecule Libraries120187310.030 Why?
National Institutes of Health (U.S.)120167930.030 Why?
Models, Biological2202194680.030 Why?
Aged, 80 and over42021589460.030 Why?
Drug Approval120208140.030 Why?
Early Detection of Cancer2201732000.030 Why?
Europe1201934200.030 Why?
Pneumonectomy1201911100.030 Why?
Ubiquitin-Protein Ligases1202218910.030 Why?
Radiopharmaceuticals1202226500.030 Why?
Neoplasm Proteins2201736110.030 Why?
Self Efficacy120166370.020 Why?
Risk Factors42020741520.020 Why?
Tumor Suppressor Proteins1202228040.020 Why?
DNA, Neoplasm1201717450.020 Why?
Base Sequence12022124490.020 Why?
Regression Analysis1202063410.020 Why?
Immunoenzyme Techniques1201417040.020 Why?
Piperidines1201916570.020 Why?
Triazoles120169030.020 Why?
Quality of Life22022133550.020 Why?
Cardiovascular Surgical Procedures120121890.020 Why?
Lymphatic Metastasis1201829140.020 Why?
Genes, Tumor Suppressor1201510620.020 Why?
Reproducibility of Results22021200920.020 Why?
Chromosome Aberrations1201617710.020 Why?
ROC Curve1201735720.020 Why?
Neoplasm Invasiveness1201735880.020 Why?
Genomic Instability120137090.020 Why?
Acetylation1201110540.020 Why?
Hydroxamic Acids120114810.020 Why?
Time Factors22020399740.020 Why?
Alleles1201969090.020 Why?
Epigenesis, Genetic1202137930.020 Why?
Health Policy1202026840.020 Why?
Chemotherapy, Adjuvant1201635120.020 Why?
DNA-Binding Proteins1202496050.020 Why?
Hypoxia-Inducible Factor 1, alpha Subunit120106170.020 Why?
Gene Knockdown Techniques1201116110.020 Why?
Prevalence12023157190.020 Why?
Kaplan-Meier Estimate1201664730.020 Why?
Patient Education as Topic1201623190.020 Why?
Cluster Analysis1201327120.020 Why?
Carcinoma1201723280.020 Why?
Histone Deacetylase Inhibitors120117740.020 Why?
Positron-Emission Tomography1202264780.020 Why?
Proteomics1201938430.020 Why?
Bone Marrow1201629090.020 Why?
Promoter Regions, Genetic1201657780.020 Why?
Research1201219770.010 Why?
Boston1201793330.010 Why?
Transcription Factors12023121220.010 Why?
Recurrence1201684700.010 Why?
Kidney1201970490.010 Why?
Transcription, Genetic1201775970.010 Why?
Transfection1201157760.010 Why?
Transplantation, Heterologous1201123850.010 Why?
Parents1201635640.010 Why?
RNA, Small Interfering1201134280.010 Why?
Histones1201125790.010 Why?
Flow Cytometry1201158660.010 Why?
Antigens, CD1201140000.010 Why?
Magnetic Resonance Imaging22021364300.010 Why?
Tomography, X-Ray Computed12022205550.010 Why?
RNA, Messenger12013127870.010 Why?
Randomized Controlled Trials as Topic12014102030.010 Why?
New York119998740.010 Why?
Genotype12010129820.010 Why?
Carcinoma, Squamous Cell1201140220.010 Why?
Cross-Sectional Studies12016261080.010 Why?
Insurance Claim Review119997390.010 Why?
Case-Control Studies12011221240.010 Why?
Socioeconomic Factors1199978240.000 Why?
Logistic Models11999132510.000 Why?
Health Services Accessibility1199954390.000 Why?
Janeway's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (401)
Explore
_
Co-Authors (163)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.